PYXS · CIK 0001782223 · operating
Pyxis Oncology, Inc. (PYXS) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $95 million, Pyxis Oncology, Inc. is a micro-cap company. The stock currently trades at $1.46, down 1.02% today, with a 52-week range of $0.83–$5.55.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.32 | $-1.32 | +28.6% | |
| 2023 | $-1.85 | $-1.85 | +49.3% | |
| 2022 | $-3.65 | $-3.65 | — | |
| 2021 | — | — | — |